A review of vilazodone, serotonin, and major depressive disorder.
about
Emerging drugs for the treatment of anxietyVilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapyVortioxetine: a New Treatment for Major Depressive Disorder.Evaluation of the efficacy and safety of vilazodone for treating major depressive disorderThe functional serotonin 1a receptor promoter polymorphism, rs6295, is associated with psychiatric illness and differences in transcriptionVilazodone: a review in major depressive disorder in adults.
P2860
A review of vilazodone, serotonin, and major depressive disorder.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A review of vilazodone, serotonin, and major depressive disorder.
@ast
A review of vilazodone, serotonin, and major depressive disorder.
@en
type
label
A review of vilazodone, serotonin, and major depressive disorder.
@ast
A review of vilazodone, serotonin, and major depressive disorder.
@en
prefLabel
A review of vilazodone, serotonin, and major depressive disorder.
@ast
A review of vilazodone, serotonin, and major depressive disorder.
@en
P2860
P356
P1476
A review of vilazodone, serotonin, and major depressive disorder.
@en
P2093
Kerri A Pierz
Michael E Thase
P2860
P356
10.4088/PCC.13R01554
P577
2014-01-09T00:00:00Z